Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
SPDR S&P Pharmaceuticals ETF (XPH) and Invesco DWA Healthcare Momentum ETF (PTH) belong to the same industry segment: US Health Care. Both ETFs have the same top 3 sector exposures: and Health Care. XPH is less expensive with a Total Expense Ratio (TER) of 0.35%, versus 0.72% for PTH. XPH is down -1.12% year-to-date (YTD) with +$88M in YTD flows. PTH performs worse with -1.66% YTD performance, and -$2M in YTD flows. Run a side-by-side ETF comparison of XPH and PTH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | XPH PTH | -3.45%-0.00% | -1.36%-3.57% | -1.12%-1.66% | +29.22%+29.38% | +42.98%+33.57% | +9.16%-9.43% |
| Flows | XPH PTH | +$12M- | +$95M-$2M | +$88M-$2M | +$111M-$12M | +$48M-$92M | +$36M-$490M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | XPH PTH | +20.33%+21.18% | +23.08%+24.52% | +19.01%+24.28% | +20.26%+25.52% |
| Max drawdown | XPH PTH | -5.97%-7.58% | -17.10%-16.12% | -23.45%-29.24% | -33.10%-50.10% |
| Max drawdown duration | XPH PTH | 14d87d | 140d183d | 322d271d | 1706d1651d |
XPH | PTH | |
Last sale 3/12/2026 at 1:34 PM | $54.05 | $48.80 |
| Previous close 03/11/2026 | $55.49 | $49.20 |
| Consolidated volume 03/11/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
XPH | PTH | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
XPH | PTH | |
|---|---|---|
| Last price | $54.05 | $48.80 |
| 1D performance | -2.60% | -0.81% |
| AuM | $313.37 M | $121.25 M |
| E/R | 0.35% | 0.72% |
XPH | PTH | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | SPDR | Invesco |
| Benchmark | S&P Pharmaceuticals Select Industry Index | Dorsey Wright Healthcare Technical Leaders Index |
| N° of holdings | 49 | 46 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 19, 2006 | October 12, 2006 |
| ESG | No | No |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.
